Caption Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,300
Closed -$49.8M 1840
2025
Q4
$49.8M Buy
+46,300
New +$44.3M 0.34% 63
2023
Q4
Sell
-18,000
Closed -$9.67M 1521
2023
Q3
$9.67M Buy
18,000
+400
+2% +$206K 0.15% 166
2023
Q2
$8.25M Sell
17,600
-19,900
-53% -$8.35M 0.15% 172
2023
Q1
$12.9M Buy
+37,500
New +$12.6M 0.25% 94
2022
Q4
Sell
-17,500
Closed -$5.66M 1512
2022
Q3
$5.66M Buy
+17,500
New +$5.54M 0.08% 301
2022
Q1
Sell
-90,000
Closed -$24.9M 1729
2021
Q4
$24.9M Buy
+90,000
New +$22.8M 0.28% 73

Other funds holding LLY

Caption Management's LLY Position: Q1 2026 in Review

Caption Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,240 shares — an estimated $5.63M sold.

Caption Management first reported a position in LLY in Q1 2018 and held it in 6 quarters. The position peaked at $6.82M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Caption Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 5,240 Eli Lilly shares in Q1 2026, an estimated $5.63M.
  • Caption Management first reported a position in Eli Lilly in Q1 2018 and held it in 6 quarters.
  • Caption Management's Eli Lilly position peaked at $6.82M in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.